These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36839767)

  • 1. Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension.
    Cavelier M; Gondé H; Costa D; Lamoureux F; Pereira T; Buchbinder N; Varin R; Hervouët C
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children.
    Fuss D; Gondé H; Lamoureux F; Pereira T; Colnot M; Buchbinder N; Coquard A; Varin R; Hervouët C
    Eur J Pharm Sci; 2021 May; 160():105738. PubMed ID: 33524504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
    Klovrzová S; Zahálka L; Kříž T; Zahálková O; Matysová L; Šklubalová Z; Horák P
    Eur J Hosp Pharm; 2016 Jan; 23(1):33-37. PubMed ID: 31156811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
    Chudiwal VS; Shahi S; Chudiwal S
    Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric oral solutions with propranolol hydrochloride for extemporaneous compounding: the formulation and stability study.
    Klovrzová S; Zahálka L; Matysová L; Horák P; Sklubalová Z
    Ceska Slov Farm; 2013 Feb; 62(1):35-9. PubMed ID: 23578266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2022; 26(4):342-351. PubMed ID: 35820140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of hydralazine hydrochloride syrup compounded from tablets.
    Alexander KS; Pudipeddi M; Parker GA
    Am J Hosp Pharm; 1993 Apr; 50(4):683-6. PubMed ID: 8470684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a safe and versatile suspension vehicle for pediatric use: Formulation development.
    Alarie H; Roullin VG; Leclair G
    Int J Pharm; 2019 Oct; 569():118552. PubMed ID: 31376465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of nicardipine hydrochloride in intravenous solutions.
    Baaske DM; DeMay JF; Latona CA; Mirmira S; Sigvardson KW
    Am J Health Syst Pharm; 1996 Jul; 53(14):1701-5. PubMed ID: 8827237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability study of a clonidine oral solution in a novel vehicle designed for pediatric patients.
    Potier A; Voyat J; Nicolas A
    Pharm Dev Technol; 2018 Dec; 23(10):1067-1076. PubMed ID: 28990851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for nicardipine hydrochloride quantification in plasma using solid-phase extraction and reversed-phase high-performance liquid chromatography.
    Fernandes CM; Veiga FJ
    Biomed Chromatogr; 2003 Jan; 17(1):33-8. PubMed ID: 12583003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid.
    Metras JI; Swenson CF; McDermott MP
    Am J Hosp Pharm; 1992 Jul; 49(7):1720-4. PubMed ID: 1621730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
    Chen P; Mar Z; Giannetti A; Hughes S; Gilbert J; Zhao F
    Hosp Pharm; 2022 Feb; 57(1):69-75. PubMed ID: 35521008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Tetracycline Hydrochloride Compounded in a Miracle Mouthwash Formulation.
    Younis US; Fazel M; Myrdal PB
    AAPS PharmSciTech; 2019 Apr; 20(5):178. PubMed ID: 31041553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
    Lin YS; Lin SC; Hsieh YT; Liu LY; Lin CH; Shen LJ; Huang CF
    Eur J Hosp Pharm; 2022 Nov; 29(6):324-328. PubMed ID: 33608396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and in vivo evaluation of membrane-moderated transdermal therapeutic systems of nicardipine hydrochloride using carvone as a penetration enhancer.
    Krishnaiah YS; Satyanarayana V; Bhaskar P
    Drug Deliv; 2003; 10(2):101-9. PubMed ID: 12746056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.
    Merino-Bohórquez V; Delgado-Valverde M; García-Palomo M; Dávila-Pousa MC; Cañete C; Villaronga M; Rodriguez-Marrodán B; López-Rojas R; Cameán-Fernández M;
    Pharm Dev Technol; 2019 Apr; 24(4):465-478. PubMed ID: 30124097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.